Abstract | BACKGROUND/AIMS: METHODS: Adult rats were fed isocaloric liquid diets containing 0% or 37% ethanol, and administered a PPARdelta agonist by i.p. injection. We used liver tissue to examine histopathology, gene expression, oxidative stress, insulin signaling, and regenerative responses to 2/3 hepatectomy. RESULTS: Chronic ethanol feeding caused insulin resistance, increased oxidative stress, lipid peroxidation, DNA damage, and hepatocellular injury in liver. These effects were associated with reduced insulin receptor binding and affinity, impaired survival signaling through PI3K/Akt/ GSK3beta, and reduced expression of insulin responsive genes mediating energy metabolism and tissue remodeling. PPARdelta agonist treatment reduced ethanol-mediated hepatic injury, oxidative stress, lipid peroxidation, and insulin resistance, increased signaling through PI3K/Akt/ GSK3beta, and enhanced the regenerative response to partial hepatectomy. CONCLUSIONS:
PPARdelta agonist administration may attenuate the severity of chronic ethanol-induced liver injury and ethanol's adverse effects on the hepatic repair by restoring insulin responsiveness, even in the context of continued high-level ethanol consumption.
|
Authors | Maoyin Pang, Suzanne M de la Monte, Lisa Longato, Ming Tong, Jiman He, Rajeeve Chaudhry, Kevin Duan, Jiyun Ouh, Jack R Wands |
Journal | Journal of hepatology
(J Hepatol)
Vol. 50
Issue 6
Pg. 1192-201
(Jun 2009)
ISSN: 1600-0641 [Electronic] Netherlands |
PMID | 19398227
(Publication Type: Journal Article, Research Support, N.I.H., Extramural)
|
Chemical References |
- 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid
- Insulin
- PPAR delta
- Phenoxyacetates
- Ethanol
- Receptor, IGF Type 1
|
Topics |
- Animals
- DNA Damage
- Ethanol
(toxicity)
- Gene Expression
(drug effects)
- Insulin
(metabolism)
- Insulin Resistance
- Lipid Peroxidation
(drug effects)
- Liver
(drug effects, injuries, pathology, physiopathology)
- Liver Regeneration
(drug effects)
- Male
- Oxidative Stress
(drug effects)
- PPAR delta
(agonists)
- Phenoxyacetates
(pharmacology)
- Rats
- Rats, Long-Evans
- Receptor, IGF Type 1
(metabolism)
- Signal Transduction
(drug effects)
|